Abstract Submission is Now Open
Join us at the 4th Annual COMPANION DIAGNOSTICS FORUM. Companion Diagnostics can provide information that is essential for the safe and effective use of a corresponding therapeutic product, sometimes for specific patient populations. Companion Diagnostics can identify patients who are most likely to benefit from that product, highlight those at increased risk for serious side effects as a result of treatment with a particular therapeutic, and monitor treatment response to a particular therapeutic.
Event topics this year include:
- Biomarkers – Discovery and Clinical Development
- Technology/Frameworks
- Precision Medicine
- Business Models and Partnerships
- Regulatory Issues
- Reimbursement
- Standardization
- Drug and Diagnostics Pricing Transparency
Keynote Speakers
Jeff Evelhoch
Vice President, Head of Translational Biomarkers
Merck & Co.
Steve Anderson
Senior Vice President
LabCorp
John Danaher
Global President
Clinical Solutions
Elsevier
Jessica Atkinson
Vice President, BioPharma Business Development
Foundation Medicine
Some of the Organizations who have Participated
Call For Abstracts
Developing and Launching Precision Diagnostics and Therapeutics
Testimonials
The lively discussions were very relevant, on topic and contributed to a very dynamic forum. The quality of speakers was excellent. Looking forward to next years’ event
Oscar Puig, BMS
Valuable information and insight in this dynamic area. Great to see old acquaintances and meet new ones
Dick Sond, Fujirebio
Great presentations and a very nice size for a conference, it enabled good discussions with other delegates.
Andrew Aijian, DecBio